„Our commitment to a greater quality of life“
Since 2001 BioPolymer has been pursuing the development of innovative injectable implants for the optimization of existing treatments and the development of new treatment methods in different medical disciplines. The aim in all areas is to optimize composition, mode of action, and injection behavior in such a way that the recipient's quality of life is improved.
The products based on the crosslinking of hyaluronic acid reveal their positive effects in orthopedics.
In addition to aesthetic medicine, products based on the crosslinking of hyaluronic acid also reveal their positive effects in fields such as urology, gynecology, surgery, and orthopedics. Due to its cross-disciplinary developments and research, BioPolymer is now one of the world's leading providers of hyaluronic acid gels.